Received Aug 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X022827 | OT |
Movement disorder; Pain in extremity; Peripheral swelling; This spontaneous report was received from a consumer or other non-health professional and refers to a 26-year-old female patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On 12-Aug-2025, the patient started therapy with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) at a dose of 0.5 mL (0.5mL / once), administered by Intramuscular route, lot number X022827 and expiration date of 14-Aug-2025 for prophylaxis. On 13-Aug-2025, the patient experienced pain from shoulder to hand and the inability to move their arm all with inflammation from the elbow to the shoulder with severe pain (pain in extremity, movement disorder and peripheral swelling). The patient sought for medical attention and received as a treatment ice packs, alternate Ibuprofen and paracetamol (TYLENOL) every 3-4 hours and prescribed a prednisone taper for 3-days. At the reporting time, the patient was recovering from the events. The causal relationship between the events and vaccination with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) was not provided. This is one of four reports received from the same reporter.